B. Riley Names The Oncology Institute Its Top Pick After Debt Refinancing
B. Riley Securities singled out The Oncology Institute as the standout investment from its May conference, citing a recent refinancing that eliminated a near-term debt deadline and strengthened the company's financial position. The firm maintained a Buy rating and an $8 price target, highlighting improved free cash flow, expectations for continued …